Literature DB >> 12807864

HIV and cardiovascular medicine.

B D Prendergast1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12807864      PMCID： PMC1767745          DOI： 10.1136/heart.89.7.793

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

1.  Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.

Authors:  D Périard; A Telenti; P Sudre; J J Cheseaux; P Halfon; M J Reymond; S M Marcovina; M P Glauser; P Nicod; R Darioli; V Mooser
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

2.  The expanding role of the cardiologist in the care of HIV infected patients.

Authors:  G Barbaro; S D Fisher; A M Pellicelli; S E Lipshultz
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 3.  Pathological findings of HIV-associated cardiovascular disease.

Authors:  G d'Amati; C R di Gioia; P Gallo
Journal:  Ann N Y Acad Sci       Date:  2001-11       Impact factor: 5.691

Review 4.  Cardiac complications of human immunodeficiency virus infection: diagnostic and therapeutic considerations.

Authors:  A Arshad; A Bansal; R C Patel
Journal:  Heart Dis       Date:  2000 Mar-Apr

5.  Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

Authors:  S E Lipshultz; K A Easley; E J Orav; S Kaplan; T J Starc; J T Bricker; W W Lai; D S Moodie; G Sopko; S D Colan
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

Review 6.  Cardiac manifestations of acquired immunodeficiency syndrome.

Authors:  P Rerkpattanapipat; N Wongpraparut; L E Jacobs; M N Kotler
Journal:  Arch Intern Med       Date:  2000-03-13

7.  Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.

Authors:  M P Dubé; D Sprecher; W K Henry; J A Aberg; F J Torriani; H N Hodis; J Schouten; J Levin; G Myers; R Zackin; T Nevin; J S Currier
Journal:  Clin Infect Dis       Date:  2000-11-07       Impact factor: 9.079

Review 8.  Cardiac manifestations of HIV infection in infants and children.

Authors:  M J Keesler; S D Fisher; S E Lipshultz
Journal:  Ann N Y Acad Sci       Date:  2001-11       Impact factor: 5.691

Review 9.  HIV-Related pulmonary hypertension: analytic review of 131 cases.

Authors:  N J Mehta; I A Khan; R N Mehta; D A Sepkowitz
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

10.  Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS.

Authors:  G Barbaro; G Di Lorenzo; B Grisorio; G Barbarini
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245
View more
  14 in total

Review 1.  Infection-related vasculitis.

Authors:  Omondi Oyoo; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

2.  The symptoms of autonomic dysfunction in HIV-positive Africans.

Authors:  Caterina Compostella; Leonida Compostella; Ruggiero D'Elia
Journal:  Clin Auton Res       Date:  2007-12-15       Impact factor: 4.435

3.  Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis.

Authors:  Susan L Rosenkranz; Kevin E Yarasheski; Michael F Para; Richard C Reichman; Gene D Morse
Journal:  Metab Syndr Relat Disord       Date:  2007-06       Impact factor: 1.894

Review 4.  Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.

Authors:  Jasimuddin Ahamed; Hunter Terry; Mary E Choi; Jeffrey Laurence
Journal:  AIDS       Date:  2016-02-20       Impact factor: 4.177

Review 5.  Myocardial disease in human immunodeficiency virus (HIV) infection: a review.

Authors:  Mahmoud Umar Sani
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection.

Authors:  Daniel B Chastain; Travis S King; Kayla R Stover
Journal:  Open AIDS J       Date:  2016-06-06

7.  A classical case of non-bacterial thrombotic endocarditis from pancreatic adenocarcinoma presenting as multiple strokes, myocardial infarction and acute limb ischaemia.

Authors:  Ching-Hui Sia; Joline Si Jing Lim; Kian Keong Poh; Tan Min Chin
Journal:  Oxf Med Case Reports       Date:  2016-11-04

8.  Assessment of Pulmonary Arterial Hemodynamic and Vascular Changes by Pulmonary Pulse Transit Time in Patients with Human Immunodeficiency Virus Infection.

Authors:  Mehmet Akif Erdol; Burak Acar; Ahmet Goktug Ertem; Mustafa Karanfil; Çağrı Yayla; Koray Demırtas; Pelin Aladağ; Meliha Çağla Sönmezer; Esra Kaya Kiliç; Çiğdem Ataman Hatipoğlu; Fatma Sebnem Erdinc; Necla Tulek; Adnan Burak Akcay
Journal:  J Cardiovasc Echogr       Date:  2021-05-21

9.  Echocardiographic patterns in treatment-naïve HIV-positive patients in Lagos, south-west Nigeria.

Authors:  D A Olusegun-Joseph; J N A Ajuluchukwu; C C Okany; A C Mbakwem; D A Oke; N U Okubadejo
Journal:  Cardiovasc J Afr       Date:  2012-07-30       Impact factor: 1.167

10.  Anolunula in Fingernails among Patients Infected with HIV.

Authors:  Pratik Gahalaut; Nitin Mishra; Sandhya Chauhan; Mir Mubashir Ali; Madhur Kant Rastogi; Richa Thakur
Journal:  ISRN Dermatol       Date:  2014-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.